公开(公告)号：US20030157079A1

公开(公告)日：2003-08-21

申请号：US10372323

申请日：2003-02-25

申请人： WAKAMOTO PHARMACEUTICAL CO., LTD.

发明人： Azusa Kato ,  Seigo Nakaya ,  Nobuyuki Suzuki ,  Haruhisa Hirata

IPC分类号： A61K045/00

CPC分类号： C12R1/225 ,  A23L29/065 ,  A23L33/10 ,  A23L33/135 ,  A23Y2220/77 ,  A61K35/747

摘要： The present invention provides a probiotics product comprising, as an effective component, lactic acid bacteria belonging to Lactobacillus salivarius possessing high adhesiveness to mucous membrane, a high proliferation ability and a high resistance to acids, a composition for preventing and/or treating digestive tract's diseases comprising the probiotics product as an effective component and a novel Lactobacillus salivarius strain possessing high adhesiveness to mucous membrane, a high proliferation ability and a high resistance to acids. The lactic acid bacteria and the probiotics product and the composition for preventing and/or treating digestive tract's diseases, which contain the lactic acid bacteria as an effective component, according to the present invention can sufficiently show their probiotics functions without being easily discharged from the digestive tract and urinogenital organs.

摘要翻译： 本发明提供一种益生菌产品，其包含属于对粘膜具有高粘附性，高增殖能力和高耐酸性的唾液乳杆菌的乳酸菌作为有效成分，用于预防和/或治疗消化道疾病的组合物 包括作为有效成分的益生菌产品和对粘膜具有高粘附性，高增殖能力和高耐酸性的新型唾液乳杆菌菌株。 根据本发明的含有乳酸菌作为有效成分的乳酸菌和益生菌产品以及用于预防和/或治疗消化道疾病的组合物可充分显示其益生菌功能，而不易从消化道排出 管道和尿生殖器官。